# FDA EIR - UCB Pharma S.A. - April 21, 2023

Source: https://www.globalkeysolutions.net/records/eir/ucb-pharma-sa/0a4d5150-1f3d-4902-a9e3-98e6c80b367f

> FDA EIR for UCB Pharma S.A. on April 21, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: UCB Pharma S.A.
- Inspection Date: 2023-04-21
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [EIR - 2022-02-04](https://www.globalkeysolutions.net/records/eir/ucb-pharma-sa/c0412e1a-bd81-4e61-8d2c-6bc873ddb1ac)
- [483 - 2022-02-04](https://www.globalkeysolutions.net/records/483/ucb-pharma-sa/4d10a705-f62a-4e4d-a1a3-bc75539da471)

## Related Officers

- [ Investigator, Consumer Safety Officer](https://www.globalkeysolutions.net/people/thuy-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [other](https://www.globalkeysolutions.net/people/hamet-m-toure/9f3726f3-b118-4247-9793-738557aa1ee8)
- [Consumer Safety Officer at FDA](https://www.globalkeysolutions.net/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- [Madushini Dharmasena](https://www.globalkeysolutions.net/people/madushini-dharmasena/c6dbff15-4c5f-475e-8ec1-581d8e65f76c)

Company: https://www.globalkeysolutions.net/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c